Rep. Maria Elvira Salazar Sells Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on October 7th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on September 24th. The trade occurred in the Representative’s “UBS IRA ACCOUNT” account.

Representative Maria Elvira Salazar also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Citigroup (NYSE:C) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Chubb (NYSE:CB) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of GE Aerospace (NYSE:GE) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Honeywell International (NASDAQ:HON) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of RH (NYSE:RH) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 9/24/2026.

UnitedHealth Group Price Performance

Shares of UNH opened at $378.82 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market cap of $340.03 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 1.39 and a beta of 0.60. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The stock has a 50 day moving average of $388.78 and a 200-day moving average of $380.29.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 19.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Analysts Set New Price Targets

A number of brokerages have issued reports on UNH. Morgan Stanley raised their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a report on Friday, July 17th. New Street Research set a $402.00 price target on UnitedHealth Group in a research report on Friday. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Zacks Research cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Finally, Bank of America reiterated a “buy” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 20th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $462.59.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts view UnitedHealth’s diversified healthcare platform, improving Medicare Advantage profitability and lower valuation as advantages over Humana. The stock’s reduced earnings multiple could provide room for a re-rating if the turnaround continues. UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
• Positive Sentiment: UnitedHealth’s third-quarter earnings are expected to rise sharply year over year, with consensus estimates near $4.12–$4.15 per share on approximately $111.4 billion in revenue. Investors are watching for cost controls, restructuring benefits and a possible increase in 2026 guidance. UnitedHealth Gears Up for Q3 Earnings
• Positive Sentiment: One investment thesis argues that UnitedHealth’s deliberate exit from unprofitable businesses is driving meaningful margin expansion despite flat revenue and lower membership. At roughly 16 times projected 2027 earnings, the shares trade below their historical average, leaving potential upside if margin gains prove durable. UnitedHealth: A Beat Is Priced In, But There’s Room For Surprise
• Neutral Sentiment: Medicare Advantage star-rating changes are reshuffling the competitive landscape. Humana benefited substantially from improved ratings, while UnitedHealth was described as holding steady; the revised methodology may affect reimbursement and enrollment trends without necessarily reflecting changes in care quality. Humana Soars on Improved Medicare Advantage Star Ratings
• Negative Sentiment: TD Cowen lowered its price target for UnitedHealth to $402, reflecting continued caution around margin repair, medical costs and subdued revenue growth. The upcoming earnings report remains an important test of management’s recovery plan. UnitedHealth Group Price Target Lowered

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. General Partner Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $512,000. PBCay One RSC Ltd bought a new position in shares of UnitedHealth Group in the 1st quarter valued at about $14,343,000. Lee Johnson Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth $6,180,000. Kinsale Capital Group Inc. increased its stake in shares of UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock valued at $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Vaughan David Investments LLC IL boosted its stake in UnitedHealth Group by 2.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock worth $49,772,000 after acquiring an additional 3,934 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.

Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.